Capivasertib
Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).
| Catalog Number | T1920 |
| Alternative Name(s) | AZD5363 |
| Research Area | Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors|||PI3K/Akt/mTOR signaling|||Autophagy |
| Molecular Formula | C21H25ClN6O2 |
| CAS# | 1143532-39-1 |
| Purity | 99.29% |
| SMILES | NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Capivasertib |
| Additional Information | https://www.targetmol.com/datasheet/T1920 |